Perbedaan Brigit Biofarmaka Teknologi Tbk. dan King Tire Indonesia Tbk.: Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp240 (kapitalisasi pasar 166,01 M, volume 24 jam 324 rb), sedangkan King Tire Indonesia Tbk. diperdagangkan di Rp110 (kapitalisasi pasar 396,79 M, volume 24 jam 13,12 jt). Perbedaan utamanya: King Tire Indonesia Tbk. jauh lebih besar — sekitar 2,4× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan King Tire Indonesia Tbk. lebih aktif diperdagangkan (13,12 jt vs 324 rb). Mana yang lebih baik tergantung tujuan investasimu.
| OBAT | TYRE | |
|---|---|---|
Kapitalisasi Pasar | 166,01 M | 396,79 M |
Volume | 324 rb | 13,12 jt |
Lot | 3,24 rb | 131,16 rb |
Perputaran | 77,68 jt | 1,6 M |
Harga Rata-rata | 239,75 | 122,35 |
Nilai Transaksi | 77,68 jt | 1,6 M |
Harga Ekuilibrium Indikatif | 240 | 110 |
Volume Ekuilibrium Indikatif | 1 | 1,51 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →PT King Tire Indonesia Tbk (the Company) was established on August 2, 2010 based on Notarial Deed No. 01 of Humberg Lie, S.H., S.E., M.Kn., notary in Jakarta. The Company started its commercial operations in 2011. The Companys immediate parent entity is PT Kingland Investindo Nusantara. The controlling interest of the Company is owned by an individual namely Harris Muliawan.
Selengkapnya di halaman TYRE →